MEDICAL WEIGHT LOSS

EXCITING UPDATES COMING!

BodyByBariatrics is thrilled to announce that we are in the process of revamping our medical weight loss program to better serve you! The entire team is working diligently to enhance the program, incorporating the latest advancements and personalized approaches to help you achieve your health and wellness goals.

During this transition period, we want to express our gratitude for your patience and understanding. We understand the importance of your journey to better health, and we are committed to providing you with the best possible support and care.

By filling out this form*, you will be among the first to receive information about our updated services so we can help you along your weight loss journey!

*By providing this information, you agree to receive communication from BodyByBariatrics. You can unsubscribe at any time.

BE TRANSFORMED

Copy of Website- Medical Weight Loss (2)

Outstanding Results.

With a focus on evidence-based weight loss medications, we ensure that you receive the support and tools needed for a transformative and sustainable weight loss journey. 

Personalized Care.

Our unwavering commitment to personalized care begins with a thorough evaluation, encompassing comprehensive lab studies and an in-depth review of your medical history. Your weight loss journey is tailored to your individual needs and goals. 

Competitive Prices.

We take pride in offering a comprehensive medical weight loss program with the most competitive pricing in the country. We work to ensure the affordability of your weight loss medications. Your journey with us is designed for exceptional value from the start. 

Effortless Communication.

We prioritize open and easy communication with our patients, ensuring your questions and concerns are addressed promptly and comprehensively. 

Text us! 407-543-0971

AM I A CANDIDATE?

Individuals with BMI > 27 kg/m²  and obesity related comorbidities (i.e., diabetes, high blood pressure, PCOS, obstructive sleep apnea, high cholesterol, etc.)

Individuals with BMI > 30 kg/m²  (regardless of presence of comorbidities)

Individuals who have previously had bariatric surgery

As a dedicated bariatric surgeon and board-certified obesity medicine specialist at BodyByBariatrics, my commitment is unwavering when it comes to helping you achieve your weight loss goals. Whether you're post-bariatric surgery or facing other weight challenges, we prescribe a range of prescription medications designed to address the aspects of weight biology that are beyond our control. These medications, backed by strong clinical evidence, are known for their effectiveness in supporting your weight loss journey. We take a personalized approach, considering various factors to determine the medication that will be both safe and affordable for your unique needs.

Copy of Website- Medical Weight Loss (3)

MEDICATIONS

Wegovy®

WEGOVY® (semaglutide) is a prescription medication used for long-term weight management in adults with obesity or those who are overweight and have weight-related medical conditions. It belongs to the class of drugs called GLP-1 receptor agonists. WEGOVY® works by mimicking the action of the hormone GLP-1, which helps regulate appetite and food intake. By increasing feelings of fullness and slowing down digestion, it supports weight loss in individuals looking to achieve and maintain a healthier body weight. 

WEGOVY® is typically administered via subcutaneous injection and is available in a pre-filled pen. The dosing regimen begins with a low dose and is gradually increased to a maintenance dose as determined by a healthcare provider. It is generally taken once a week on the same day each week. The dosing regimen may vary depending on individual needs and the specific formulation of WEGOVY® prescribed.

The benefits of WEGOVY® are profound for individuals struggling with obesity. It helps control appetite, making it easier for individuals to consume fewer calories, ultimately leading to weight loss. The weight loss achieved with WEGOVY® can have a significant impact on overall health, reducing the risk of obesity-related complications such as cardiovascular problems, diabetes, and joint issues. Additionally, WEGOVY® can enhance self-esteem and overall quality of life by supporting weight loss and healthier body composition. 

WEGOVY® can bring about life-changing health improvements. Weight loss often results in increased physical activity, better sleep quality, and improved mental well-being. Individuals may experience higher energy levels, reduced joint pain, and increased mobility. Achieving a healthier body weight can lead to an improved sense of self-esteem and overall well-being. 

While generally well-tolerated, WEGOVY® can cause side effects. Common side effects include nausea, diarrhea, vomiting, and abdominal pain. These side effects are often mild and tend to improve over time. It is important for individuals using WEGOVY® to communicate with Dr. Dovec about side effects, as they can often be managed or may require dose adjustments.

WEGOVY® may interact with other medications, so it is crucial for patients to inform Dr. Dovec about all the drugs they are taking. Particular attention should be given to medications that affect the gastrointestinal system and those that may influence appetite or food intake to avoid potential contraindications or adverse interactions. 

WEGOVY® is contraindicated in individuals with a history of severe gastrointestinal disease and in those with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It is not recommended for use in individuals with type 1 diabetes or diabetic ketoacidosis.

WEGOVY® has some important warnings. It is not a treatment for type 1 diabetes or diabetic ketoacidosis, and careful monitoring of blood sugar levels is essential for individuals using it. WEGOVY® also carries a warning about the potential risk of thyroid tumors, so individuals with a history of MTC or MEN 2 should not use this medication. Patients should be monitored for signs of thyroid tumors, and routine thyroid testing may be necessary. Regular follow-up visits and close monitoring by a healthcare provider are crucial to ensure safe and effective use. Any concerning symptoms or side effects should be reported promptly. 

Mounjaro®

mounjaro_logo

Mounjaro® is a prescription drug FDA approved for the treatment of type 2 diabetes. It operates by targeting multiple pathways in the body to regulate blood sugar levels and promote weight loss. Mounjaro® is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. It stimulates the release of insulin when blood sugar levels are elevated and reduces glucagon, a hormone that raises blood sugar. This combination helps maintain tighter control over blood sugar fluctuations. Additionally, it slows down gastric emptying, promoting a feeling of fullness and reducing food intake, contributing to weight loss. Overall, Mounjaro® offers a comprehensive approach to managing type 2 diabetes by addressing both glucose control and obesity.

Mounjaro® comes in an injection given at doses which start at 2.5 mg once weekly. Dosing instructions vary according to weight, tolerability and other factors. The initial dose is often lower to minimize the risk of gastrointestinal side effects, such as nausea. Mounjaro® is available in six different doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg). Dr. Dovec will ensure you are slowly titrated up until therapeutic once you reach a maximum dose of 15 mg weekly injections.

Data from various studies reveal significant benefits of Mounjaro®. It can lead to substantial reductions in body weight and fat mass, enhance energy intake reduction and appetite control. The medication also shows a relationship between improved glycemic control and body weight reduction. Moreover, it helps individuals reach glycemic and weight targets more rapidly compared to other treatments. 

Mounjaro® can be life-changing for people with type 2 diabetes. It helps manage key aspects of the disease by reducing weight, improving energy intake, and enhancing glycemic control. The results suggest that it can have a profound impact on health outcomes for these individuals. 

Common side effects reported in Mounjaro®-treated patients include nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, and abdominal pain. There are also potential severe side effects, such as pancreatitis, hypoglycemia, hypersensitivity reactions, and acute kidney injury. 

Mounjaro® may interact with other medications, especially those that affect insulin secretion. Caution should be exercised when combining Mounjaro® with other drugs to minimize the risk of hypoglycemia and ensure proper absorption.

Mounjaro®  is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). This is due to a risk of thyroid C-cell tumors. 

Mounjaro® carries a warning about the risk of thyroid C-cell tumors. Patients should be monitored for symptoms of thyroid tumors, and routine monitoring of serum calcitonin is recommended. The medication also has a potential risk of pancreatitis, and patients should be observed for signs and symptoms of this condition. Additionally, hypersensitivity reactions may occur, and caution should be exercised in patients with a history of angioedema or anaphylaxis. Mounjaro® also poses a risk of acute kidney injury in patients with severe gastrointestinal adverse reactions. It may affect patients with diabetic retinopathy and should be used cautiously in such cases. The drug can be contraindicated in patients with severe gastrointestinal disease and may cause acute gallbladder disease. Finally, Mounjaro® has not been studied in pediatric patients under 18 years of age. 

Ozempic®

OZEMPIC® (semaglutide) is a prescription medication used to manage blood sugar levels in adults with type 2 diabetes. It belongs to a class of drugs called GLP-1 receptor agonists. OZEMPIC® works by mimicking the action of the hormone GLP-1, which helps regulate blood sugar levels by increasing insulin secretion and reducing the liver’s glucose production. It also slows down digestion and reduces appetite, making it an effective tool in managing diabetes. 

OZEMPIC® is administered via subcutaneous injection and is available in a pre-filled pen. The dosing typically starts with a low dose and is gradually increased to the maintenance dose as determined by a healthcare provider. It is usually taken once a week on the same day each week. The dosing regimen may vary depending on individual needs and the specific formulation of OZEMPIC® prescribed. 

The benefits of OZEMPIC® are profound for individuals with type 2 diabetes. It helps improve blood sugar control by lowering both fasting and post-meal glucose levels. This can lead to a reduced risk of diabetes-related complications, including cardiovascular issues and kidney problems. Furthermore, OZEMPIC® may support weight loss, which is often a challenge for individuals with diabetes. By reducing appetite and slowing digestion, it can assist patients in achieving and maintaining a healthier body weight, contributing to overall well-being. 

For many individuals, OZEMPIC® can be life-changing. It not only helps regulate blood sugar but can also lead to significant improvements in overall health. Better glycemic control reduces the risk of diabetic complications, such as neuropathy, retinopathy, and cardiovascular disease. Weight loss achieved with OZEMPIC® can improve mobility, alleviate joint pain, and enhance overall quality of life. Additionally, stable blood sugar levels can lead to increased energy and a better sense of well-being. 

While generally well-tolerated, OZEMPIC® can have side effects. Common side effects include nausea, vomiting, diarrhea, and abdominal pain. These side effects are often mild and tend to improve over time. It is important for individuals using OZEMPIC® to communicate with their healthcare provider about side effects, as they can often be managed or may require dose adjustments. 

OZEMPIC® may interact with other medications, and it is essential for patients to inform their healthcare provider about all the drugs they are taking. Particular attention should be given to drugs that affect the gastrointestinal system and those that may influence blood sugar levels to avoid potential contraindications or adverse interactions. 

OZEMPIC® is contraindicated in individuals with a history of severe gastrointestinal disease and individuals with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). It is not recommended for use in individuals with type 1 diabetes or diabetic ketoacidosis.

OZEMPIC® has some important warnings. It is not a treatment for type 1 diabetes or diabetic ketoacidosis, and careful monitoring of blood sugar levels is essential for individuals using it. OZEMPIC® also carries a warning about the potential risk of thyroid tumors, so individuals with a history of MTC or MEN 2 should not use this medication. Patients should be monitored for signs of thyroid tumors, and routine thyroid testing may be necessary. Additionally, OZEMPIC® should not be used in patients with severe kidney impairment. Regular follow-up visits and close monitoring by a healthcare provider are crucial to ensure safe and effective use. Any concerning symptoms or side effects should be reported promptly.

Zepbound®

Zepbound Logo

Zepbound is an injectable prescription medicine that may help adults with obesity, or with excess weight (overweight) who also have weight related medical problems, lose weight and keep it off. Zepbound works by mimicking two hormones (GLP-1 and GIP) made by the intestines. It is the first combination peptide to get FDA approval for obesity. These two gut hormones are essential to the body, and they improve feelings of fullness and insulin sensitivity and delay gastric emptying (the time it takes for food to leave the stomach for the small intestines). 

Zepbound comes in an injection given at doses which start at 2.5 mg once weekly. Dosing instructions vary according to weight, tolerability and other factors.The initial dose is often lower to minimize the risk of gastrointestinal side effects, such as nausea. Zepbound is available in six different doses (2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, and 15 mg). Dr. Dovec will ensure you are slowly titrated up until therapeutic once you reach a maximum dose of 15 mgweekly injections. 

Data from various studies reveal significant benefits of Zepbound. It can lead to substantial reductions in body weight and fat mass, enhance energy intake reduction and appetite control. The medication also shows a relationship between improved glycemic control and body weight reduction. Moreover, it helps individuals reach glycemic and weight targets more rapidly compared to other treatments. 

Zepbound can be life-changing for people with a BMI > 27 kg/m2 who are struggling with obesity and its associated issues. It helps manage key aspects of the disease by reducing weight, improving energy intake, and enhancing glycemic control. The results suggest that it can have a profound impact on health outcomes for these individuals.

Common side effects reported in Zepbound-treated patients include nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, and abdominal pain. There are also potential severe side effects, such as pancreatitis, hypoglycemia, hypersensitivity reactions, and acute kidney injury.

Zepboundcontains tirzepatide. Coadministration with other tirzepatide-containing products or with any glucagon-like peptide-1 (GLP-1) receptor agonist is not recommended. Zepbound may interact with other medications, especially those that affect insulin secretion. Caution should be exercised when combining  Zepbound with other drugs to minimize the risk of hypoglycemia and ensure proper absorption. The safety and efficacy of Zepbound in combination with other products intended for weight management, including prescription drugs, over-the-counter drugs, and herbal preparations, have been established

Zepbound  is contraindicated in patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). This is due to a risk of thyroid C-cell tumors.Zepbound has not been studied in patients with a history of pancreatitis.  

Zepboundcarries a warning about the risk of thyroid C-cell tumors. Patients should be monitored for symptoms of thyroid tumors, and routine monitoring of serum calcitonin is recommended. The medication also has a potential risk of pancreatitis, and patients should be observed for signs and symptoms of this condition. Additionally, hypersensitivity reactions may occur, and caution should be exercised in patients with a history of angioedema or anaphylaxis. Zepboundalso poses a risk of acute kidney injury in patients with severe gastrointestinal adverse reactions. It may affect patients with diabetic retinopathy and should be used cautiously in such cases. The drug can be contraindicated in patients with severe gastrointestinal disease and may cause acute gallbladder disease. Finally, Zepboundhas not been studied in pediatric patients under 18 years of age.

Contrave®

contrave

CONTRAVE® is a prescription medication that combines two active ingredients, naltrexone and bupropion, to address weight management in individuals struggling with obesity. Naltrexone is primarily an opioid receptor antagonist, and bupropion is a compound with multiple mechanisms of action, including acting as a norepinephrine and dopamine reuptake inhibitor. These components work together to influence the brain’s reward system, appetite regulation, and energy expenditure, thereby assisting individuals in achieving and maintaining weight loss. It is designed to be used as an adjunct to a reduced-calorie diet and increased physical activity, offering a comprehensive approach to weight management. 

CONTRAVE® is typically administered in tablet form, and the dosing regimen involves gradual titration to minimize side effects. The initial dose usually consists of one tablet in the morning, which contains 8 mg of naltrexone and 90 mg of bupropion. The dose is then increased gradually to reach a maintenance dose of two tablets in the morning and two tablets in the evening, providing a total daily dose of 32 mg of naltrexone and 360 mg of bupropion. The goal is to find the appropriate dose that balances effectiveness and tolerability for each individual. If Dr. Dovec is prescribing the generic components of CONTRAVE® separately, she will discuss the dosing regimen for this. 

The benefits of CONTRAVE® can be profound for individuals struggling with obesity. It not only aids in weight loss but also offers significant improvements in overall health. The medication helps to reduce body weight, waist circumference, and body mass index (BMI), which can lead to a decreased risk of obesity-related comorbidities such as type 2 diabetes, cardiovascular disease, and sleep apnea. Additionally, CONTRAVE® may improve patients’ quality of life by enhancing their self-esteem and overall well-being through the achievement of weight loss goals. 

CONTRAVE® can be life-changing for many individuals as it addresses the physical and emotional aspects of obesity. By promoting weight loss, it contributes to improved glycemic control, reduces blood pressure, and enhances lipid profiles, which are all crucial components of cardiovascular health. Furthermore, weight loss can alleviate joint pain, increase mobility, and improve sleep quality, leading to a significant enhancement in overall health and quality of life. The psychological benefits of achieving weight loss goals can also be profound, boosting self-confidence and mental well-being. 

Like any medication, CONTRAVE® is associated with potential side effects. Common side effects include nausea, constipation, headache, dizziness, and insomnia. These side effects are often mild to moderate in severity and tend to diminish over time as the body adjusts to the medication. It’s important for individuals using CONTRAVE® to discuss side effects with Dr. Dovec, as some can be managed or may require dose adjustments. 

CONTRAVE® can interact with other medications, particularly those that affect the central nervous system. For instance, it may interact with opioids, certain antidepressants, antipsychotic medications, and drugs that lower the seizure threshold. Patients should inform Dr. Dovec of all the medications they are taking to ensure there are no potential contraindications or adverse interactions. 

CONTRAVE® is contraindicated in individuals with a history of seizures or eating disorders, as it may increase the risk of seizures. It is also not recommended for use in individuals with uncontrolled hypertension, as the medication can raise blood pressure. Additionally, individuals who are using opioids or undergoing opioid withdrawal should not use CONTRAVE® due to the naltrexone component. 

There are several important warnings associated with CONTRAVE®. These include the risk of seizures, elevated blood pressure, and the potential for psychiatric side effects such as mood and behavior changes, including suicidal thoughts and actions. Individuals taking CONTRAVE® should be closely monitored, especially during the early stages of treatment, and any concerning symptoms or side effects should be reported to Dr. Dovec or a healthcare provider promptly. Patients should also be advised on the importance of gradual dose titration to minimize side effects and maximize safety. 

Phentermine

Phentermine is a prescription medication used primarily for weight management in individuals with obesity or those who are overweight and have weight-related medical conditions. It is a sympathomimetic amine, working as an appetite suppressant by stimulating the release of norepinephrine in the brain. Phentermine helps individuals achieve and maintain a healthier weight.  

Phentermine is typically administered in the form of oral tablets. The dosing regimen usually starts with a low to moderate dose, as outlined by Dr. Dovec, taken once daily in the morning before breakfast. The dosage may be adjusted based on individual response and tolerability.  

The benefits of Phentermine can be profound, especially in the context of short-term weight management. It is known for its appetite-suppressing effects, which can lead to reduced caloric intake and, consequently, weight loss. Phentermine helps individuals shed excess weight, leading to improvements in various health indicators such as reduced blood pressure, lower cholesterol levels, and improved glycemic control. Weight loss achieved with Phentermine can also alleviate the strain on joints and muscles, enhancing mobility and overall well-being. 

Phentermine can bring about life-changing health improvements for those struggling with obesity. Weight loss achieved with Phentermine often leads to increased physical activity, better sleep quality, and improved self-esteem, ultimately resulting in a higher quality of life. Many individuals experience improved energy levels and mental well-being as they work towards and achieve their weight loss goals. 

While Phentermine can be an effective weight management tool, it may cause side effects. Common side effects include dry mouth, insomnia, increased heart rate, nervousness, and constipation. These side effects are often temporary and can be managed with proper guidance. It is important for individuals using Phentermine to report any side effects to Dr. Dovec or their healthcare professional. 

Phentermine may interact with other medications, including monoamine oxidase inhibitors (MAOIs), other weight loss medications, and certain antidepressants. Patients should inform Dr. Dovec about all the medications they are taking to ensure there are no potential contraindications or adverse interactions. Phentermine’s effects on the central nervous system should be considered when using it alongside other drugs affecting the central nervous system. 

Phentermine is contraindicated in individuals with a history of heart disease, uncontrolled high blood pressure, hyperthyroidism, glaucoma, and a history of substance abuse, as it may exacerbate these conditions. It is also contraindicated during pregnancy and breastfeeding due to potential risks to the developing fetus and the infant. 

Phentermine comes with several important warnings. It should be used with caution in individuals with a history of mental health conditions, including depression and anxiety, as it may exacerbate these conditions. Prolonged use of Phentermine can lead to tolerance, where its effects diminish over time, making it less effective. It is vital for individuals to adhere to their healthcare provider’s recommendations and use Phentermine as part of a comprehensive weight management plan. Also, it is not recommended for long-term use due to the potential for dependence and addiction, making careful monitoring essential during the treatment period. 

Medical FAQs

Medications will be billed to your insurance and cost will depend on your coverage and plan. We will work with our prior authorization team and the pharmacy to ensure insurance is used appropriately and all applicable discounts are applied.

Yes, you can use HSA or FSA accounts for the program fee and any copays. You are not able to use them for a la carte meal plans, however.

We will send you a lab order form to get completed at the lab of your choice. The labs required are:

  • CBC with Differential
  • CMP
  • Folic Acid
  • Hemoglobin A1c
  • Insulin
  • Iron
  • Lipids
  • Prealbumin
  • PTH
  • TSH
  • Vitamin B1
  • Vitamin B12
  • Vitamin D

We use these labs to determine eligibility for certain medications and to provide recommendation for any additional supplementation required. If you are unable to get them prior to your visit, we can either wait to prescribe a medication until they are available or move your appointment to the next month.

We will review your past medical history, including your recent labs, and choose an appropriate medication. We will also factor in what is covered by your insurance or is affordable for you.

We will work closely with you to troubleshoot any intolerance you experience and prescribe alternative medications as necessary.

If your insurance does not cover injectable medications, you can choose to pay for the medication out of pocket (price set per the manufacturer) or we will work with you to find an appropriate generic oral medication that is more cost effective.

YOUR MEDICAL WEIGHT LOSS JOURNEY STARTS NOW